Центральный научно-исследовательский рентгенорадиологический институт
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Центральный научно-исследовательский рентгенорадиологический институтfiledCriticalЦентральный научно-исследовательский рентгенорадиологический институт
Priority to SU4426456/14ApriorityCriticalpatent/SU1534778A1/en
Application grantedgrantedCritical
Publication of SU1534778A1publicationCriticalpatent/SU1534778A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
FIELD: medicine, and namely, surgery. SUBSTANCE: magnetohard ferrite is injected into the vessel feeding the tumor, and single is conducted for 29-30 min. EFFECT: reduced general intoxication, reduced dissemination of tumor cells.
SU4426456/14A1988-05-311988-05-31Method of treatment of tumors
SU1534778A1
(en)
Process of treating tumors and macular degeneration in a human or veterinary patient, pharmaceutical composition for treating tumors and macular degeneration in a human or veterinary patient
Treatment of malignant tumors with 8-chloroadenosine 3',5'-cyclic phosphate, 8-aminoadenosine 3',5'-cyclic phosphate and preparation thereof.